NN2211; Victoza; D06404
HAEGTFTSDVSSYLEGQAAK [N-(1-oxohexadecyl)-L-γ-glutamyl] EFI AWLVRGRG
Long-term Storage Conditions
Marketed under the brand name Victoza, liraglutide is an injectable drug developed for the treatment of type 2 diabetes.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion.
Areas of Interest